Difference between revisions of "Team:Lethbridge/Entrepreneurship"
Keithaiken (Talk | contribs) |
|||
| Line 5: | Line 5: | ||
<html> | <html> | ||
<body> | <body> | ||
| − | <div class="content"> | + | <div class="content"> <!--everything added for content goes after this line--> |
<br><br> | <br><br> | ||
| Line 38: | Line 38: | ||
</div> | </div> | ||
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
| − | + | </div> <!--this closes off the content div--> | |
| − | </div> | + | |
</body> | </body> | ||
</html> | </html> | ||
Revision as of 19:41, 13 October 2018
ENTREPRENEURSHIP
The Lethbridge iGEM team has a history of developing novel targeted delivery methods. In 2014, the Lethbridge team began development of an innovative cell therapy platform designed to non-invasively deliver a therapeutic genetic construct to neural scars to promote functional recovery from stroke, traumatic brain injury, and neurodegenerative disease (for more information, see the 2014 Lethbridge Wiki). Since the 2014 season, two members of the current 2018 Lethbridge team, Aubrey and Zak, have been committed to patenting and commercializing this technology under the start-up, Nomadogen Biotechnologies Inc., which was incorporated in February of 2015.
Company Profile
Nomadogen was initially founded by four graduate student members of the 2014 Lethbridge iGEM team: Zak Stinson, Aubrey Demchuk, Scott Wong, and Evan Caton. Three of the Founders (Zak, Aubrey, and Scott) currently constitute the Board of Directors.
